Filing Details
- Accession Number:
- 0001209191-13-007870
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-02-11 19:19:06
- Reporting Period:
- 2013-02-11
- Filing Date:
- 2013-02-11
- Accepted Time:
- 2013-02-11 19:19:06
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
949699 | Pharmacyclics Inc | PCYC | Pharmaceutical Preparations (2834) | 943148201 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1412679 | J Joseph Buggy | C/O Pharmacyclics, Inc. 995 East Arques Avenue Sunnyvale CA 94085-4521 | Vp, Research | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2013-02-11 | 12,000 | $0.86 | 18,701 | No | 4 | M | Direct | |
Common Stock | Disposition | 2013-02-11 | 12,000 | $69.97 | 6,701 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | Disposition | 2013-02-11 | 12,000 | $0.00 | 12,000 | $0.86 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
81,313 | 2008-03-18 | 2018-03-18 | No | 4 | M | Direct |
Footnotes
- Sale of shares pursuant to Rule 10b5-1 Plan adopted on January 10, 2013.
- The shares subject to the option will vest as follows: 25% of the shares subject to the option will vest on March 18, 2009 and 1/36th of the remaining shares will vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested on March 18, 2012, subject to the Reporting Person's continued employment or service relationship with the Issuer on each of the vesting dates.